Breo Ellipta
Generic: fluticasone furoate vilanterol
Manufacturer: GlaxoSmithKline (GSK) · Program: GSK Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or underinsured; does not cover government insurance beneficiaries
Residency
US resident
Income Threshold
Up to 300% FPL
Individual Income Limit
$75,000/year
for uninsured patients at or below 300% FPL
Program Information
Processing Time
2-4 weeks
Delivery Method
shipped to patient
Application Method
Multiple
Reauthorization
Required — annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- proof of income
- proof of residency
- prescription
- insurance status
Indicated For
asthma, COPD
About This Medication
# GSK Patient Assistance Program Patient Guide: How to Get Breo Ellipta at Low or No Cost Breo Ellipta (fluticasone furoate and vilanterol) is a prescription inhaler used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. The **GSK Patient Assistance Program** offers this medication at no cost to eligible uninsured or underinsured patients who meet income and other requirements.[1][2] ## About Breo Ellipta **Breo Ellipta** combines two active ingredients: fluticasone furoate, an inhaled corticosteroid that reduces inflammation in the airways, and vilanterol, a long-acting beta agonist (LABA) that relaxes airway muscles to improve breathing. It's taken once daily via a handheld inhaler device that's easy to use—no shaking required. Patients activate it by opening the cover and sliding the mouthpiece, then inhale deeply. It's approved for long-term maintenance treatment, not for sudden breathing attacks (use a rescue inhaler like albuterol for those).[1] Common side effects include thrush (oral yeast infection, preventable by rinsing mouth after use), headache, cough, and upper respiratory infections. Serious risks include worsening breathing, pneumonia in COPD patients, and potential heart effects. Always follow your doctor's instructions and report side effects to your healthcare provider or FDA at 1-800-FDA-1088.[1] ## Who Qualifies for the Program? The GSK Patient Assistance Program, managed by the independent GSK Patient Access Programs Foundation, provides free GSK medicines like Breo Ellipta to qualifying patients. Key eligibility criteria include: - **Residency**: Live in the US, Puerto Rico, or US Virgin Islands (for certain products).[4] - **Income**: Household income at or below **300% of the Federal Poverty Level (FPL)**. For 2026, this approximates $75,000 for an individual, $100,000 for a couple, $125,000 for a family of 3, and $150,000 for a family of 4 (exact limits adjust annually; confirm via program).[1][7] - **Insurance**: Primarily for **uninsured patients**. Medicare Part D patients may qualify if they've spent $600+ on prescriptions that year and meet stricter income limits (e.g., $47,880 for household of 1).[4][7] - **Treatment**: Prescribed by a US-licensed healthcare provider.[4] - **Other**: No government insurance like Medicaid (except specific Medicare cases); not for commercial insurance copays.[1][2] ## Income Eligibility Breakdown Eligibility is based on **gross household income** (before taxes) compared to 300% FPL for uninsured patients. Use total people in household, including yourself and dependents. Here's a simplified table (2026 estimates; call program for exact figures as FPL updates yearly): | Household Size | Max Annual Income (300% FPL, Contiguous US) | |----------------|---------------------------------------------| | 1 | $45,180 | | 2 | $61,320 | | 3 | $77,460 | | 4 | $93,600 | | Each additional| +$16,140 | **Notes**: Alaska and Hawaii have higher limits (e.g., Alaska household of 1: ~$56,490). Medicare patients have lower thresholds (e.g., household of 1: $47,880). Provide proof like tax returns or pay stubs.[1][7] ## Insurance Requirements - **Uninsured**: Fully eligible if income-qualified. - **Underinsured/Medicare Part D**: Possible if you've met the $600 true out-of-pocket spend and lower income limits; submit Part D ID and proof of spend.[2][4][7] - **Exclusions**: No coverage for Medicaid, Medicare Advantage, VA, Tricare, or state-funded programs. Private insurance patients should explore GSK copay programs instead.[1][6] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Use the GSKForYou quiz at gskforyou.com or call **(888) 825-5249**.[1] 2. **Get a Prescription**: Ask your doctor for a signed Breo Ellipta prescription (faxed from office if faxing).[2] 3. **Download/Request Application**: Get the form from gskpaf.org or call 1-866-728-4368.[2][4] 4. **Complete the Form**: Fill Section 1 (your info, household size, income), note allergies, sign consents.[2][3] 5. **Gather Documents**: - Proof of income (e.g., 2025 tax return, W-2s, pay stubs covering 4 weeks). - Proof of residency (utility bill, lease). - Prescription. - Insurance status (none or Medicare card/proof of $600 spend).[2][3] 6. **Submit**: Fax to 1-855-474-3063 or mail to PO Box 220590, Charlotte, NC 28222. Include patient name/DOB on all.[2][8] 7. **Track Status**: Call 1-866-728-4368.[4] **Tip**: Keep copies; don't send originals.[2] ## Timeline and Delivery Processing takes **2-4 weeks** after complete submission. Incomplete apps delay approval. Once approved, medication ships free directly to your home (not doctor's office). Initial supply is typically 12 months; refills available online or by phone.[1][4] ## Reauthorization and Refills **Reauthorization is required** annually or when income/insurance changes. Request refills via gskpaf.org portal, app, or 1-866-728-4368 up to 12 months post-approval.[1][4] ## Alternatives if Denied - **Appeal**: Call to discuss reasons (e.g., income proof issue) and resubmit.[4] - **Copay Cards**: Private insurance? Check GSKForYou savings offers.[1] - **Other PAPs**: NeedyMeds.org or RxAssist.org for generics/alternatives.[9] - **State Programs**: Contact local health department for COPD/asthma aid. - **Generic Options**: No biosimilars listed, but discuss Advair Diskus (similar GSK product) or generics like fluticasone/salmeterol with your doctor. - **Patient Advocacy**: Groups like COPD Foundation or American Lung Association offer resources.[1] ## Important Disclaimer This guide is for informational purposes only and not medical/financial advice. Program details can change; always verify with GSK at 1-866-728-4368 or gskpaf.org. Eligibility isn't guaranteed. Consult your doctor before starting/stopping Breo Ellipta. GSK PAP doesn't replace insurance. Income tables are estimates—use official FPL calculators. Last reviewed based on available 2026 data.
Program information last verified: March 30, 2026
Ready to apply for Breo Ellipta assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.